Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Strategies targeting angiogenesis in advanced non-small cell lung cancer.

Wang J, Chen J, Guo Y, Wang B, Chu H.

Oncotarget. 2017 May 17;8(32):53854-53872. doi: 10.18632/oncotarget.17957. eCollection 2017 Aug 8. Review.

2.

MicroRNA-187 modulates epithelial-mesenchymal transition by targeting PTRF in non-small cell lung cancer.

Cai Y, Ruan J, Yao X, Zhao L, Wang B.

Oncol Rep. 2017 May;37(5):2787-2794. doi: 10.3892/or.2017.5548. Epub 2017 Apr 3.

PMID:
28393200
3.

Polymorphisms of insulin receptor substrate 2 are putative biomarkers for pediatric medulloblastoma: considering the genetic susceptibility and pathological diagnoses.

Baocheng W, Zhao Y, Meng W, Han Y, Wang J, Liu F, Qin S, Ma J.

Nagoya J Med Sci. 2017 Feb;79(1):47-54. doi: 10.18999/nagjms.79.1.47.

4.

Oxymatrine Inhibits Proliferation and Migration While Inducing Apoptosis in Human Glioblastoma Cells.

Liu F, Wang B, Wang J, Ling X, Li Q, Meng W, Ma J.

Biomed Res Int. 2016;2016:1784161. Epub 2016 Nov 13.

5.

Interference with Protease-activated Receptor 1 Alleviates Neuronal Cell Death Induced by Lipopolysaccharide-Stimulated Microglial Cells through the PI3K/Akt Pathway.

Li Y, Yang W, Quinones-Hinojosa A, Wang B, Xu S, Zhu W, Yu F, Yuan S, Lu P.

Sci Rep. 2016 Dec 2;6:38247. doi: 10.1038/srep38247.

6.

Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer.

Wang J, Kalhor N, Hu J, Wang B, Chu H, Zhang B, Guan Y, Wu Y.

PLoS One. 2016 Oct 3;11(10):e0163397. doi: 10.1371/journal.pone.0163397. eCollection 2016.

7.
8.

Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations.

Wang J, Wang B, Chu H, Yao Y.

Onco Targets Ther. 2016 Jun 22;9:3711-26. doi: 10.2147/OTT.S106399. eCollection 2016. Review.

9.

The clinical diagnosis and management options for intracranial juvenile xanthogranuloma in children: based on four cases and another 39 patients in the literature.

Wang B, Jin H, Zhao Y, Ma J.

Acta Neurochir (Wien). 2016 Jul;158(7):1289-97. doi: 10.1007/s00701-016-2811-7. Epub 2016 May 13. Review.

PMID:
27173098
10.

Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition).

Guo J, Qin S, Liang J, Lin T, Si L, Chen X, Chi Z, Cui C, Du N, Fan Y, Gu K, Li F, Li J, Li Y, Liang H, Liu J, Lu M, Lu A, Nan K, Niu X, Pan H, Ren G, Ren X, Shu Y, Song X, Tao M, Wang B, Wei W, Wu D, Wu L, Wu A, Xu X, Zhang J, Zhang X, Zhang Y, Zhu H; written on behalf of Chinese Society of Clinical Oncology (CSCO) Melanoma Panel.

Chin Clin Oncol. 2016 Aug;5(4):57. doi: 10.21037/cco.2015.12.02. Epub 2015 Dec 17. No abstract available.

11.

Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition).

Guo J, Qin S, Liang J, Lin T, Si L, Chen X, Chi Z, Cui C, Du N, Fan Y, Gu K, Li F, Li J, Li Y, Liang H, Liu J, Lu M, Lu A, Nan K, Niu X, Pan H, Ren G, Ren X, Shu Y, Song X, Tao M, Wang B, Wei W, Wu D, Wu L, Wu A, Xu X, Zhang J, Zhang X, Zhang Y, Zhu H; written; Chinese Society of Clinical Oncology (CSCO) Melanoma Panel.

Ann Transl Med. 2015 Dec;3(21):322. doi: 10.3978/j.issn.2305-5839.2015.12.23. Review. No abstract available.

12.

miR-96 suppresses renal cell carcinoma invasion via downregulation of Ezrin expression.

Yu N, Fu S, Liu Y, Xu Z, Liu Y, Hao J, Wang B, Zhang A.

J Exp Clin Cancer Res. 2015 Sep 29;34:107. doi: 10.1186/s13046-015-0224-8.

13.

Synergistic antitumor responses by combined GITR activation and sunitinib in metastatic renal cell carcinoma.

Yu N, Fu S, Xu Z, Liu Y, Hao J, Zhang A, Wang B.

Int J Cancer. 2016 Jan 15;138(2):451-62. doi: 10.1002/ijc.29713. Epub 2015 Aug 18.

14.
15.

Tangeretin enhances radiosensitivity and inhibits the radiation-induced epithelial-mesenchymal transition of gastric cancer cells.

Zhang X, Zheng L, Sun Y, Wang T, Wang B.

Oncol Rep. 2015 Jul;34(1):302-10. doi: 10.3892/or.2015.3982. Epub 2015 May 15.

PMID:
25998143
16.

Association of androgen receptor exon 1 CAG repeat length with risk of hepatocellular carcinoma: a case-control study.

Li K, Zhong C, Wang J, Wang B, He J, Bi J.

Tumour Biol. 2014 Dec;35(12):12519-23. doi: 10.1007/s13277-014-2570-0. Epub 2014 Sep 14. Retraction in: Tumour Biol. 2017 Apr 20;:.

PMID:
25217983
17.

Regulation of the P2X7R by microRNA-216b in human breast cancer.

Zheng L, Zhang X, Yang F, Zhu J, Zhou P, Yu F, Hou L, Xiao L, He Q, Wang B.

Biochem Biophys Res Commun. 2014 Sep 12;452(1):197-204. doi: 10.1016/j.bbrc.2014.07.101. Epub 2014 Jul 28.

PMID:
25078617
18.

Boosting-based EMG patterns classification scheme for robustness enhancement.

Li Z, Wang B, Yang C, Xie Q, Su CY.

IEEE J Biomed Health Inform. 2013 May;17(3):545-52.

PMID:
24592457
19.

Benign and malignant renal cells are differentially inhibited during prolonged organ preservation.

Yu N, Fu S, Liu Y, Fu Z, Meng J, Xu Z, Wang B, Zhang A.

PLoS One. 2013 Dec 9;8(12):e81745. doi: 10.1371/journal.pone.0081745. eCollection 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/b51ed377-9d16-4082-b714-369fc36a8a22. Liu, Yibao [corrected to Liu, Yubao].

20.

Investigation on XRCC1 genetic polymorphism and its relationship with breast cancer risk factors in Chinese women.

Zheng L, Yang F, Zhang X, Zhu J, Zhou P, Yu F, Hou L, Zhao G, He Q, Wang B.

Med Oncol. 2013 Dec;30(4):738. doi: 10.1007/s12032-013-0738-x. Epub 2013 Oct 25.

PMID:
24277466

Supplemental Content

Loading ...
Support Center